--- title: "Medispa Valuation Multiples UK 2026 | DealFlowAgent Blog" description: "UK medispa EBITDA multiples range from 4x to 12x in 2026. Expert guide to aesthetics clinic valuations, buyer types and sale preparation." lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "Organization", "@id": "https://www.dealflowagent.com/#organization", "name": "DealFlowAgent", "alternateName": "DealFlow Agent", "url": "https://www.dealflowagent.com", "logo": { "@type": "ImageObject", "url": "https://www.dealflowagent.com/media/a8c3dd54-ab81-40f5-995e-50fda69ec528.webp", "width": 512, "height": 512 }, "image": "https://www.dealflowagent.com/og-image.webp", "description": "DealFlowAgent is the leading specialist M&A advisor for building services and facilities management businesses, including fire and life safety, electrical, water hygiene and Legionella, lift and elevator maintenance, HVAC, plumbing and security, plus specialist healthcare clinics and care homes across the UK and US. £500K–£100M.", "foundingDate": "2024", "founders": [ { "@type": "Person", "name": "Joe Lewin", "jobTitle": "Founder & Managing Director" } ], "address": { "@type": "PostalAddress", "streetAddress": "Battersea Power Station", "addressLocality": "London", "addressCountry": "GB", "postalCode": "SW11" }, "contactPoint": [ { "@type": "ContactPoint", "telephone": "+44-20-7293-0327", "contactType": "sales", "availableLanguage": [ "English" ] }, { "@type": "ContactPoint", "email": "joe@dealflowagent.com", "contactType": "customer service" } ], "sameAs": [ "https://www.linkedin.com/company/dealflowagent", "https://twitter.com/dealflowagent" ], "areaServed": [ { "@type": "Country", "name": "United Kingdom" }, { "@type": "Country", "name": "United States" } ], "knowsAbout": [ "Mergers and Acquisitions", "Business Valuation", "Exit Planning", "M&A Advisory", "Business Sale", "Private Equity", "Building Services M&A", "Facilities Management M&A", "Fire and Life Safety M&A", "Electrical Contracting M&A", "Water Hygiene and Legionella Compliance M&A", "Lift and Elevator Maintenance M&A", "HVAC Business Sales", "Plumbing Business Sales", "Testing, Inspection and Certification M&A", "Healthcare Clinics and Care Home M&A" ], "slogan": "The specialist M&A advisor for building services, facilities management and healthcare." }, { "@context": "https://schema.org", "@type": "WebSite", "@id": "https://www.dealflowagent.com/#website", "url": "https://www.dealflowagent.com", "name": "DealFlowAgent", "description": "Specialist M&A advisory for building services, facilities management and healthcare business owners in the UK and USA", "publisher": { "@id": "https://www.dealflowagent.com/#organization" }, "potentialAction": { "@type": "SearchAction", "target": { "@type": "EntryPoint", "urlTemplate": "https://www.dealflowagent.com/blog?q={search_term_string}" }, "query-input": "required name=search_term_string" }, "inLanguage": "en" }, { "@context": "https://schema.org", "@type": "Article", "headline": "Medispa Valuation Multiples UK 2026", "description": "UK medispa EBITDA multiples range from 4x to 12x in 2026. Expert guide to aesthetics clinic valuations, buyer types and sale preparation.", "url": "https://www.dealflowagent.com/blog/medispa-clinic-valuation-multiples-uk-2026", "image": "https://images.unsplash.com/photo-1552693673-1bf958298935?w=1200&h=670&fit=crop&q=80", "author": { "@type": "Organization", "name": "DealFlowAgent", "url": "https://www.dealflowagent.com" }, "publisher": { "@type": "Organization", "name": "DealFlowAgent", "logo": { "@type": "ImageObject", "url": "https://www.dealflowagent.com/social-share-thumbnail.webp" } }, "datePublished": "2026-03-27T06:30:00+00:00" }, { "@context": "https://schema.org", "@type": "VideoObject", "name": "Introduction to DealFlowAgent from founder Joe Lewin", "description": "Joe Lewin, founder of DealFlowAgent, explains how the firm helps owners of building services, facilities management and healthcare businesses run a confidential, competitive sale process with 13,000+ vetted acquirers.", "thumbnailUrl": [ "https://dealflowagent.com/og-image.png" ], "uploadDate": "2026-08-05", "embedUrl": "https://www.tella.tv/video/vid_cmqs8w3m300c004jp8jf79ugo/embed?b=0&title=0&a=1&loop=1&t=0&muted=0&wt=0&o=0", "contentUrl": "https://www.tella.tv/video/vid_cmqs8w3m300c004jp8jf79ugo", "publisher": { "@type": "Organization", "name": "DealFlowAgent", "url": "https://dealflowagent.com" } } ] --- [![DealFlowAgent](/assets/dealflowagent-logo-white-BtiUZq_y.webp)](/) Sectors Refer an Owner [Valuation Guides](/valuation/guides)[Exit Planning](/exit-planning)[Blog](/blog)Book a Confidential Call[Careers](/careers) [🇬🇧 +44 20 7293 0327](tel:+442072930327)| [🇺🇸 +1 (447) 837-9720](tel:+14478379720) [Whatsapp](https://wa.me/442072930327)[I'm an Owner](/valuation)[I'm a Buyer](/buyside) [](https://wa.me/442072930327)Book a Call Share [](https://www.linkedin.com/feed/?shareActive=true&text=Sharing%20this%20for%20the%20owners%20and%20advisers%20in%20my%20network%20working%20in%20building%20services%20and%20healthcare.%20Medispa%20Valuation%20Multiples%20UK%202026.%20It%20is%20a%20clear%2C%20practical%20read%20on%20how%20buyers%20actually%20price%20these%20businesses%2C%20where%20value%20quietly%20leaks%20before%20a%20sale%2C%20and%20what%20can%20be%20fixed%20in%20the%20twelve%20months%20before%20a%20process%20starts.%20Useful%20whether%20or%20not%20an%20exit%20is%20close.%0A%0Ahttps%3A%2F%2Fwww.dealflowagent.com%2Fblog%2Fmedispa-clinic-valuation-multiples-uk-2026)[](https://twitter.com/intent/tweet?text=Medispa%20Valuation%20Multiples%20UK%202026%0A%0A&url=https%3A%2F%2Fwww.dealflowagent.com%2Fblog%2Fmedispa-clinic-valuation-multiples-uk-2026)[](https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.dealflowagent.com%2Fblog%2Fmedispa-clinic-valuation-multiples-uk-2026) ![Medispa Valuation Multiples UK 2026](/covers/medispa-clinic-valuation-multiples-uk-2026.jpg) M&A Strategy # Medispa Valuation Multiples UK 2026 UK medispa clinics are selling at 4x to 12x EBITDA in 2026. Learn what drives aesthetics valuations, who is buying, and how to prepare your clinic for a premium exit. March 27, 2026 14 min read ![Joe Lewin](/media/a224fe8e-41a2-4c4e-a1b7-6b50b6c697db.webp) Author: Joe Lewin [LinkedIn](https://www.linkedin.com/in/jp-lewin/) Bio DealFlowAgent is a leading specialist in niche healthcare, with dedicated M&A advisory and brokerage coverage for medispa and aesthetic clinic businesses across the UK and US. We help owners secure multiple acquisition offers at higher valuations. [Sell your medispas & aesthetic clinics business](/healthcare/medispas) ## What is your business worth today? Enter your website and our M&A team will prepare a written valuation and exit optimisation report. No cost, no credit card, no obligation. Strictly confidential Get Your Free Valuation Report **Strictly confidential.** Your personalized report is prepared by our internal team alone — the founder, head of M&A and associates. It is never shown to buyers or anyone outside the deal team without your permission. Already know your number? Get your free buyer list instead [Learn more about the valuation and value drivers report](/valuation) _Serving business owners across the **United Kingdom and United States**_ The UK aesthetics market is on course to exceed £3.6 billion in 2026, with annual growth running between 8% and 9%. For [medispa clinic owners considering a sale](/healthcare/medispas), that growth translates directly into stronger buyer interest and rising valuation multiples. Whether you run a single-site Botox and dermal filler clinic in a regional town or a multi-location aesthetic platform across major cities, the M&A market for medispas has never been more active. Private equity firms, healthcare consolidators and strategic acquirers are all competing for quality medispa assets. Skingevity launched in February 2026 with the [acquisition of three leading UK clinics](https://finance.yahoo.com/news/skingevity-launches-uk-medical-aesthetics-083000483.html), backed by former Goldman Sachs and Boston Consulting Group principals. Bupa acquired The Dermatology Partnership from August Equity in late 2024, adding seven specialist clinics to its direct-to-consumer healthcare portfolio. Y1 Capital's Electiva Healthcare has been on an aggressive acquisition spree across Scottish and English aesthetics practices. These are not isolated events - they represent a structural shift in how institutional capital views the UK medical aesthetics sector. This guide breaks down what your medispa clinic is worth in the current market, what drives multiples higher or lower, and how to position your business for a premium exit. ## What Are Medispa EBITDA Multiples in 2026? Medispa valuations in the UK sit within a well-defined range, driven primarily by revenue scale, treatment mix, recurring revenue models and clinical governance. The table below sets out current EBITDA multiple benchmarks based on [transaction data from Scope Research](https://www.scoperesearch.co/post/med-spa-and-aesthetics-valuation-multiples-and-m-a-trends-2025) and [FOCUS Investment Banking's 2026 dashboard](https://focusbankers.com/medspa-valuation-multiples/). Revenue Tier Typical EBITDA Multiple Key Drivers Under £500K revenue 2x - 4x EBITDA Owner-dependent, single practitioner, limited treatment range £500K - £2M revenue 3x - 6x EBITDA Small team, growing patient base, some treatment diversification £2M - £5M revenue 5x - 8x EBITDA Multi-practitioner, membership models, established brand £5M - £15M revenue 7x - 10x EBITDA Multi-site, strong management layer, diversified revenue £15M+ revenue (platform) 10x - 15x EBITDA Regional or national brand, proven acquisition playbook, institutional-grade reporting Standalone medispa clinics typically transact at 4x to 7x EBITDA. Operators that demonstrate true platform characteristics - multi-location scale, recurring membership revenue, strong brand equity and device-based operating leverage - can command 10x to 12x EBITDA. Medspas tied to physician-led practices or surgical centres often earn a 1x to 3x EBITDA premium over standalone sites, reflecting the clinical supervision advantages and higher-acuity procedure capabilities. For context, the broader UK medical practice market sees EBITDA multiples of 6x to 12x depending on specialty and scale. Dermatology platforms with aesthetic ancillaries currently trade at 12x to 15x EBITDA at the top end, making aesthetics one of the most sought-after sub-sectors in healthcare M&A. ## Why Medispa Valuations Are Rising Several structural factors are pushing medispa multiples upward in 2026. ### Cash-Pay Revenue Model Unlike most healthcare businesses that depend on NHS contracts or insurance reimbursement, medispas operate almost entirely on a cash-pay basis. Buyers love this. There is no reimbursement risk, no coding complexity and no payer concentration. Revenue is driven by consumer demand, which according to [PolicyBee's 2026 industry analysis](https://www.policybee.co.uk/blog/aesthetics-industry-statistics) continues to grow at 8% to 9% annually in the UK alone. ### Recurring Treatment Demand Botox requires repeat treatments every three to four months. Dermal fillers last six to eighteen months. Skin rejuvenation programmes run over multiple sessions. This built-in repeat cycle gives medispas a naturally recurring revenue base that acquirers value highly. Clinics that have formalised this through membership or subscription plans command premium multiples. ### Incoming Regulation Creates a Moat The UK Government is introducing a [mandatory licensing scheme for aesthetic practitioners in 2026](https://www.harleyacademy.com/aesthetic-medicine-articles/call-for-aesthetics-licensing-scheme-for-practitioners-in-2026/). The House of Commons Women and Equalities Commission has pressed for accelerated regulatory action, with licensing requirements expected to cover both practitioners and premises. [Research from UCL](https://www.ucl.ac.uk/news/2026/feb/rise-uk-aesthetic-botulinum-toxin-industry-outpacing-regulation) identified 19,701 practitioners across 5,589 clinics in the UK, many operating without adequate clinical oversight. For well-run, compliant medispas, this regulation is a significant competitive advantage. Clinics already registered with [Save Face](https://www.saveface.co.uk/en/page/join-the-save-face-register) (the government-approved register for medical aesthetics), accredited by the [JCCP](https://www.jccp.org.uk) (Joint Council for Cosmetic Practitioners), or operating under CQC registration where required will find themselves in a strengthened market position. Less compliant operators will either need to invest heavily in meeting new standards or exit the market entirely - both scenarios that benefit established clinics. ### Explosive Market Growth The UK aesthetic medicine market generated USD 1.85 billion in revenue in 2024 and is projected to reach USD 7.53 billion by 2033, representing a compound annual growth rate of 17% according to [Grand View Research](https://www.grandviewresearch.com/horizon/outlook/aesthetic-medicine-market/uk). Injectable treatments such as Botox and dermal fillers now account for 65% of the UK aesthetics market's total revenue. The global aesthetic injectables market grew from USD 13.97 billion in 2025 to USD 15.45 billion in 2026, and the trajectory shows no signs of slowing. ## Preparing Your Medispa for Sale Achieving a premium multiple requires preparation that typically begins 18 to 24 months before going to market. Here are the areas that matter most to buyers. ### Reduce Owner Dependence The single biggest value killer in medispa transactions is owner dependence. If you are the lead practitioner performing 60% or more of treatments, buyers will discount your valuation significantly. Build a team of qualified practitioners who can maintain patient relationships and treatment outcomes without your daily involvement. Hire a clinic manager who handles day-to-day operations. Document all clinical protocols, treatment plans and standard operating procedures. Ensure your Patient Management System captures comprehensive treatment records that are not tied to a single practitioner's personal notes. ### Clean Your Financial Reporting Buyers and their advisers will scrutinise your financials in detail. Separate personal expenses from business costs. Ensure your accounts clearly distinguish between treatment revenue streams - injectables, laser treatments, skin rejuvenation, body contouring and retail product sales. Present at least three years of clean management accounts showing EBITDA progression. Calculate your adjusted EBITDA by adding back owner salary, one-off costs, personal vehicle expenses and any other items that would not continue under new ownership. This normalised figure is what buyers will multiply to arrive at your enterprise value. Our [complete guide to EBITDA optimisation](/blog/ebitda-optimization-secrets-7-strategies-increase-business-value-45-percent) covers seven strategies that consistently increase business value. ### Formalise Recurring Revenue Clinics with membership or subscription models command the highest multiples. If you do not already offer a membership programme, introduce one that bundles regular treatments (such as quarterly Botox with annual skin assessments) at a slight discount. This gives buyers confidence in revenue predictability and patient retention. Track and report your patient retention rate, average revenue per patient, treatment frequency and membership renewal rates. These operational KPIs are as important as financial statements during due diligence. ### Invest in Clinical Governance With the new regulatory framework approaching, buyers are placing increased weight on clinical governance structures. Ensure you have documented prescribing protocols, adverse event reporting procedures, up-to-date practitioner training records and proper medical indemnity insurance for all staff. If your clinic performs [CQC-regulated activities](https://abaestheticconsultant.co.uk/do-aesthetic-clinics-require-cqc-registration/), your registration must be current and inspection ratings strong. ## The Buyer Landscape for UK Medispas The medispa acquisition market in the UK is being driven by several distinct buyer types, each with different motivations and valuation approaches. ### PE-Backed Platform Builders Private equity firms are the most active buyers in UK aesthetics M&A. They acquire a "platform" clinic or group and then bolt on smaller practices to build scale. Y1 Capital's Electiva Healthcare exemplifies this strategy - acquiring La Belle Forme in Scotland and partnering with MYA Cosmetic Surgery to [expand its UK-wide network](https://electiva.co.uk/electiva-healthcare-a-breakthrough-first-year-of-bold-growth/). Skingevity, backed by former Goldman Sachs and BCG professionals, is pursuing the same playbook with its initial three-clinic acquisition. These buyers typically pay 5x to 8x EBITDA for add-on acquisitions and 8x to 12x for platforms. If you are interested in understanding how [PE-backed buyers evaluate acquisition targets](/buyside), the key metrics are EBITDA margin, revenue per practitioner, patient retention and geographic positioning. ### Strategic Healthcare Groups Large healthcare operators like Bupa are entering aesthetics through strategic acquisitions. [Bupa's acquisition of The Dermatology Partnership](https://www.bupa.com/news-and-press/press-releases/2024/bupa-health-services-acquires-the-dermatology-partnership) from August Equity in late 2024 signals that major corporates see dermatology and aesthetics as a core growth channel in direct-to-consumer healthcare. These buyers often pay premium multiples because they can extract synergies through their existing patient networks, marketing infrastructure and clinical governance frameworks. ### International Consolidators Cross-border interest in UK aesthetics is growing. The February 2026 launch of Skingevity, founded by Italian professionals with experience at Goldman Sachs and BCG, illustrates how international capital is targeting UK clinics. As the UK market matures and regulation tightens, it becomes more attractive to sophisticated overseas buyers who value regulatory clarity and market structure. ### Individual Practitioner Buyers Qualified aesthetic practitioners looking to step into ownership represent a significant buyer pool for smaller clinics. These transactions tend to be at the lower end of the multiple range (3x to 5x EBITDA) and often involve seller financing or earn-out structures. They can, however, complete quickly with less complex due diligence. ## The Sale Process for a Medispa Clinic A typical medispa sale process runs between six and twelve months from initial preparation to completion. Here is what to expect. ### Phase 1: Valuation and Preparation (Months 1-3) Your adviser will conduct a thorough valuation, analysing your financial performance, patient data, treatment mix, staff contracts and property arrangements. This phase includes normalising your financials, identifying value drivers and addressing any red flags before going to market. ### Phase 2: Marketing and Buyer Identification (Months 3-5) A confidential information memorandum is prepared and shared with pre-qualified buyers. Your adviser maintains confidentiality throughout - staff, patients and competitors should not learn of the sale at this stage. The right adviser will have existing relationships with PE firms, healthcare consolidators and strategic buyers active in UK aesthetics. ### Phase 3: Offers and Negotiation (Months 5-7) Shortlisted buyers submit indicative offers. These will typically include an enterprise value (expressed as an EBITDA multiple), proposed deal structure (cash, equity rollover, earn-out), and post-completion expectations regarding your continued involvement. ### Phase 4: Due Diligence and Completion (Months 7-12) The selected buyer conducts detailed financial, legal, clinical and operational due diligence. For medispas, this will include a deep review of practitioner qualifications, treatment protocols, patient consent processes, clinical governance documentation and regulatory compliance. TUPE regulations will apply to your staff, and any property leases will need to be assignable or renegotiated. Our guide on [red flags that kill M&A deals](/blog/red-flags-kill-ma-deal-how-to-fix) outlines the issues that most commonly derail healthcare transactions. ### Tax Considerations If you are planning to sell before April 2026, the current [Business Asset Disposal Relief](https://www.gov.uk/hmrc-internal-manuals/capital-gains-manual/cg64174) rate of 14% applies to qualifying gains up to the £1 million lifetime limit. From 6 April 2026, this rate [increases to 18%](https://www.uktaxpolicymap.com/taxing-work-and-wealth/business-asset-disposal-relief-and-investors--relief-rate-increase.aspx). For a clinic selling at £2 million, this change could represent an additional £40,000 in CGT on the first £1 million of qualifying gains. Early preparation and tax planning with your accountant is essential. ## What Makes a Medispa Worth More? Beyond the fundamentals of revenue and EBITDA, specific characteristics drive medispa valuations to the upper end of the multiple range. **Treatment diversification.** Clinics offering a broad range of services - injectables, laser treatments, skin rejuvenation, body contouring, medical-grade skincare and wellness services - command higher multiples than those relying heavily on a single treatment type. The trend toward [medical wellness and longevity services](https://thebespokeadvantage.com/the-booming-and-unregulated-uk-aesthetics-market/) is creating additional revenue streams, with 34% of aesthetics practices now offering these treatments. **Technology investment.** Device-heavy medispas using advanced laser platforms, radiofrequency equipment and subscription-based treatment models attract stronger buyer interest. According to FOCUS Investment Banking, device-driven medispa models map to medtech multiples of 8.2x to 14.4x EBITDA. **Strong brand and patient loyalty.** Clinics with recognisable brands, active social media presence, genuine patient testimonials and high Google review ratings are worth more. Patient lifetime value is a critical metric - buyers want to see that patients return repeatedly over multiple years. **Geographic positioning.** Practices in affluent urban areas with high disposable income demographics command premium multiples. However, buyers also value clinics in underserved areas where competition is limited and growth potential is significant. **Data and systems.** Modern patient management systems, CRM tools, online booking platforms and automated marketing funnels demonstrate operational maturity. Buyers want businesses that can scale - and scalability depends on systems, not individuals. You can find more about how DealFlowAgent supports business owners through this process in our guides on [selling a pest control business](/blog/pest-control-business-valuation-uk-2026) and [selling a landscaping business](/blog/selling-landscaping-business-uk-guide-2026), which cover similar valuation principles across different service sectors. ## Frequently Asked Questions ### How much is my medispa clinic worth? Most standalone UK medispa clinics sell for between 4x and 7x EBITDA. A clinic generating £200,000 in annual EBITDA would typically be valued between £800,000 and £1.4 million. Clinics with multiple locations, membership models and strong clinical governance can command 8x to 12x EBITDA. ### What EBITDA multiple do medspas sell for in the UK? Small medspas with revenue under £2 million typically sell for 3x to 6x EBITDA. Mid-sized clinics with revenue between £2 million and £5 million achieve 5x to 8x EBITDA. Larger multi-site platforms with revenue above £5 million can reach 7x to 12x EBITDA, with exceptional platforms achieving even higher multiples. ### Who is buying medispa clinics in the UK? Private equity firms are the most active buyers, operating through platform and bolt-on acquisition strategies. Strategic healthcare groups like Bupa are entering the space. New consolidation platforms like Skingevity and Electiva Healthcare are acquiring multiple clinics to build national networks. Individual practitioners also acquire smaller single-site clinics. ### How long does it take to sell a medispa? A typical sale process takes six to twelve months from preparation to completion. Complex transactions involving multiple sites, regulatory considerations or international buyers may take longer. Starting preparation 18 to 24 months before your target sale date gives you time to optimise your business and maximise value. ### Will the new UK aesthetics regulation affect my valuation? Yes, positively - if you are already compliant. The incoming mandatory licensing scheme for aesthetic practitioners and premises will raise barriers to entry and force non-compliant operators to invest or exit. Clinics with Save Face accreditation, JCCP registration, strong clinical governance and CQC registration where applicable will be more valuable to buyers who need assurance of regulatory readiness. ### What is the best time to sell a medispa? Market conditions in 2026 are favourable, with strong buyer demand and rising multiples. The BADR tax rate increases from 14% to 18% from April 2026, making earlier completion advantageous for tax purposes. Seasonally, aesthetics revenue tends to peak in autumn and winter - selling after a strong Q4 demonstrates earning power. ### Do I need to stay on after selling my medispa? Most PE buyers expect the selling owner to remain for a transition period of 12 to 24 months, particularly if the owner is a key practitioner. Some buyers require an equity rollover of 20% to 30%, allowing the seller to benefit from future growth. Strategic buyers like Bupa may be more flexible on transition terms if the management team is strong. ### How do I prepare my medispa for sale? Focus on reducing owner dependence, building a strong practitioner team, formalising membership or subscription revenue, cleaning financial reporting, investing in clinical governance documentation and ensuring regulatory compliance. Begin this preparation 18 to 24 months before going to market. ### What due diligence will a buyer conduct? Buyers will review financial accounts, tax returns, patient data (anonymised), treatment protocols, practitioner qualifications, insurance policies, property leases, staff contracts (with TUPE implications), regulatory registrations, equipment maintenance records and clinical governance documentation. Aesthetic-specific due diligence will focus heavily on clinical safety records and practitioner compliance. ### Should I use an M&A adviser to sell my medispa? An experienced healthcare M&A adviser adds significant value through buyer identification, competitive tension in the process, deal structuring and negotiation expertise. Advisers with specific aesthetics sector knowledge understand the buyer landscape and can identify PE firms and consolidators actively seeking medispa acquisitions. The commission typically ranges from 3% to 6% of the transaction value, often recovering many times that in a higher sale price. ## Take the Next Step The UK medispa market is in a period of unprecedented buyer demand, rising valuations and structural consolidation. As we covered in our analysis of [healthcare business exits](/blog/healthcare-business-exits-medical-practice-worth-40-percent-more), medical practices are consistently achieving higher valuations than many owners expect. If you are considering a sale in 2026 or 2027, the preparation you do now will directly impact the multiple you achieve. DealFlowAgent specialises in connecting medispa and aesthetic clinic owners with PE-backed platforms, strategic healthcare buyers and international consolidators. Our intelligence-led deal matching identifies the buyers most likely to pay a premium for your specific clinic profile. [Book a confidential valuation call](/contact) to understand what your medispa is worth in today's market and how to position for a premium exit. ## Related reading - [Healthcare M&A overview](/healthcare) - [Specialist clinics M&A](/healthcare/clinics) - [All sector valuation guides](/valuation/guides) - [Exit planning guide for owners](/exit-planning) - [Free valuation estimate](/valuation) - [See who is buying: free buyer list](/buyer-match) - [Book a confidential call](/contact) ## Sources - [Care Quality Commission](https://www.cqc.org.uk/) - [Business Asset Disposal Relief, GOV.UK](https://www.gov.uk/business-asset-disposal-relief) Your Advisory Team ## Experienced Dealmakers Lead Your Exit A senior M&A bench, plus a sector specialist recruited for your industry on every deal. ![Head of M&A, identity blurred until official announcement](/assets/head-of-ma-blurred-v4-kTIE5QBK.jpg) Announcing Soon ### Head of M&A Joining 22 August 2026, name announcing soon Joining full-time on 22 August 2026 from the largest M&A advisory firm in the UK, owned by K3 Capital. As an ex-Director he managed teams of M&A advisors, analysts and associates, working daily with business owners, buyers and stakeholders on live acquisition deals. Selected from 260 applicants alongside colleagues from investment banking backgrounds, he brings that experience and network to lead the advisory bench across Building Services, Facilities Management, and Healthcare. Read full bio Joining full-time on 22 August 2026 from the largest M&A advisory firm in the UK, owned by K3 Capital. As an ex-Director he managed teams of M&A advisors, analysts and associates, working daily with business owners, buyers and stakeholders on live acquisition deals. Selected from 260 applicants alongside colleagues from investment banking backgrounds, he brings that experience and network to lead the advisory bench across Building Services, Facilities Management, and Healthcare. ![Martin Watson, Senior Building Services & FM Advisor at DealFlowAgent](/__l5e/assets-v1/9be3db54-9672-4a9e-9b11-bb57e662ddc3/martin-watson.jpg) Industry Specialist ### Martin Watson Senior Building Services & FM Advisor [](https://www.linkedin.com/in/martinwatson) Martin is one of the most well-connected figures in UK fire, security, building services and FM. He is Chairman of both the Fire Industry Association and the British Security Industry Association, the only person in the UK to hold both roles simultaneously. Martin spent over a decade in senior leadership at Mitie, latterly as Industry Liaison Director for its fire and security division, helping scale the business past £500m in revenue and playing a role in the £366m acquisition of Marlowe plc, which created one of the UK's largest compliance, fire and security services groups. He joined DealFlowAgent because owners in these sectors deserve a genuine sector-specialist advisor across valuation, business optimisation and buyer access. In recognition of his industry roles, he acts in a personal, non-partisan capacity. Read full bio Martin is one of the most well-connected figures in UK fire, security, building services and FM. He is Chairman of both the Fire Industry Association and the British Security Industry Association, the only person in the UK to hold both roles simultaneously. Martin spent over a decade in senior leadership at Mitie, latterly as Industry Liaison Director for its fire and security division, helping scale the business past £500m in revenue and playing a role in the £366m acquisition of Marlowe plc, which created one of the UK's largest compliance, fire and security services groups. He joined DealFlowAgent because owners in these sectors deserve a genuine sector-specialist advisor across valuation, business optimisation and buyer access. In recognition of his industry roles, he acts in a personal, non-partisan capacity. ![Nick Barker, Industry Partner at DealFlowAgent and founder of FM Talent Partners](/images/nick-barker-fm-talent-partners.png) Industry Partner ### Nick Barker Industry Partner, Hiring and Leadership [](https://www.linkedin.com/in/nickbarker1/) Nick leads FM Talent Partners, the facilities management and real estate leadership search firm, and is a leading specialist in building services and FM management talent. He partners with DealFlowAgent on two-way referrals: helping business owners and acquirers fill the key roles that decide whether a business is sellable, and introducing owners who are thinking about their next chapter to a team that knows their industry and their market. Key-person dependency is one of the two most common reasons a sale collapses, and Nick fixes it at source. Read full bio Nick leads FM Talent Partners, the facilities management and real estate leadership search firm, and is a leading specialist in building services and FM management talent. He partners with DealFlowAgent on two-way referrals: helping business owners and acquirers fill the key roles that decide whether a business is sellable, and introducing owners who are thinking about their next chapter to a team that knows their industry and their market. Key-person dependency is one of the two most common reasons a sale collapses, and Nick fixes it at source. ![James Duboullay](/assets/james-duboullay-7K417Rji.jpg) ### James Duboullay Senior M&A Advisor - • 25+ years across investment banking, M&A and fundraising - • Sector focus: essential services and software - • Long-standing relationships with private equity buyers and growth funds - • Personally advising DealFlowAgent founders for the past four years Read full bio - • 25+ years across investment banking, M&A and fundraising - • Sector focus: essential services and software - • Long-standing relationships with private equity buyers and growth funds - • Personally advising DealFlowAgent founders for the past four years ![Emerson Patton](/assets/emerson-patton-B1xTuqDt.jpg) ### Emerson Patton Sector Specialist: Building Services & Facilities Management - • 20+ years advising owners in building services, fire safety, HVAC, plumbing, and construction - • Guided 200+ companies through growth, profit improvement, and exit planning - • Builds equity value and operational structure long before a sale - • Partners with DFA to prepare owners for exit while the advisory team runs the sale Read full bio - • 20+ years advising owners in building services, fire safety, HVAC, plumbing, and construction - • Guided 200+ companies through growth, profit improvement, and exit planning - • Builds equity value and operational structure long before a sale - • Partners with DFA to prepare owners for exit while the advisory team runs the sale ![Kaya Kesici](/assets/kaya-kesici-BgkHgPoR.jpeg) ### Kaya Kesici M&A Advisor, Fire Safety, Security & Compliance - • 17 completed M&A transactions over the past six years across UK SME fire safety, security and compliance-led services - • Sell-side and buy-side experience, buyer research, acquirer mapping, outreach and live process coordination - • Information request lists, databook prep, IC-style summaries and EV-to-equity bridge work - • Direct sector exposure across fire protection, security systems, CCTV, access control and intruder alarms Read full bio - • 17 completed M&A transactions over the past six years across UK SME fire safety, security and compliance-led services - • Sell-side and buy-side experience, buyer research, acquirer mapping, outreach and live process coordination - • Information request lists, databook prep, IC-style summaries and EV-to-equity bridge work - • Direct sector exposure across fire protection, security systems, CCTV, access control and intruder alarms Previously [![Ranger Fire & Security](/assets/ranger-fire-security-l11Opbce.jpg)](https://rangerfs.com/ "Ranger Fire & Security")[![Complii](/assets/complii-DafeX_ZO.png)](https://www.complii.com/ "Complii") Ranger Fire & Security · Complete Building Services · Compliance Group ![Joe Lewin](/assets/joe-lewin-BSqoYwSF.webp) ### Joe Lewin Founder, DealFlowAgent [](https://www.linkedin.com/in/jp-lewin/) - • 22 completed M&A transactions - • Direct relationships with hundreds of strategic and financial acquirers - • Previously built a mobility and field services business to 30 staff and 6 UK warehouses, then sold via competitive process with an EY M&A partner - • Raised £2m in funding; placed 3rd of 1,900 at OnStage (the "Y Combinator of Europe") - • Full-stack developer of advanced agent systems and second-brain tooling for the M&A process Read full bio - • 22 completed M&A transactions - • Direct relationships with hundreds of strategic and financial acquirers - • Previously built a mobility and field services business to 30 staff and 6 UK warehouses, then sold via competitive process with an EY M&A partner - • Raised £2m in funding; placed 3rd of 1,900 at OnStage (the "Y Combinator of Europe") - • Full-stack developer of advanced agent systems and second-brain tooling for the M&A process [Call: 020 7293 0327](tel:+442072930327) Recruited Per Deal ### Sector Expert Industry-Specific Advisor For every engagement we add a sector specialist from your industry to the core team: a 15–25 year operator or advisor with direct relationships in your niche. Recruited per deal so you get the right fit, not a generalist. Read full bio For every engagement we add a sector specialist from your industry to the core team: a 15–25 year operator or advisor with direct relationships in your niche. Recruited per deal so you get the right fit, not a generalist. The bench is growing. Two senior M&A hires confirmed for late July 2026, selected from 200+ applicants out of Goldman Sachs, Deutsche Bank, EY, KPMG and leading boutique M&A firms. [See open roles →](/careers) Proprietary Technology ### The AI layer behind every advisor Two in-house AI systems work alongside the human bench. They are software, not people, built and supervised by the advisory team. ![Sage, AI agent](/assets/sage-avatar-ZCGsJYPl.webp) AI Agent #### Sage AI Deal Concierge Available 24/7. Monitors every signal in your deal and keeps the advisory team one step ahead. Trained on thousands of M&A transactions. ![Sterling, AI agent](/assets/sterling-profile-D8TSq_mZ.webp) AI Agent #### Sterling Buy-Side Deal Origination Agent Engages 13,000+ acquirers to surface live mandates and intent, then feeds your advisors with warm, ranked buyer matches. Free tool ## The Exit Readiness Scorecard Score your business across the factors acquirers underwrite, including key-person dependency, contract quality, customer concentration and earnings quality. Complete it below, print it, or download the PDF and work through it with your leadership team. [Open the scorecard](/tools/exit-readiness-scorecard.html)[Download the PDF](/downloads/dfa-exit-readiness-scorecard-2026-27.pdf)[Get your free valuation](/valuation) Two minutes ## Watch the intro from our founder, Joe Two minutes on how DealFlowAgent runs a confidential, competitive sale process for owners of building services, facilities management and healthcare businesses. Loading video... Medispas & Aesthetic Clinics M&A Specialists ### Thinking of selling your medispas & aesthetic clinics business? DealFlowAgent is a leading specialist in niche healthcare, with dedicated M&A advisory and brokerage coverage for medispa and aesthetic clinic businesses across the UK and US. Our trusted advisors leverage industry knowledge, buyer relationships and proprietary technology to help business owners secure multiple acquisition offers at higher valuations. [Learn about our Medispas & Aesthetic Clinics expertise](/healthcare/medispas) [Book a confidential call](/contact) Your next step ### What would you like to do next? Pick the path that matches where you are right now. All three are free. [ #### Get my valuation 60-second calculator using current 2026 multiples for your sector. Calculate ](/valuation?utm_source=blog_post&utm_medium=conversion_card&utm_campaign=valuation&utm_content=medispa-clinic-valuation-multiples-uk-2026)[ #### See who would buy it Free buyer list. Matched from 13,000+ active acquirers in the UK and US. Get buyer list ](/buyer-match?utm_source=blog_post&utm_medium=conversion_card&utm_campaign=buyer_match&utm_content=medispa-clinic-valuation-multiples-uk-2026) [Book a 20-minute call with Joe](/contact?utm_source=blog_post&utm_medium=conversion_card&utm_campaign=book_call&utm_content=medispa-clinic-valuation-multiples-uk-2026) No obligation. UK and US. Typical response within one working day. JL ### Joe Lewin Exited entrepreneur and M&A advisor who has guided 20+ business owners through successful exits. Joe built and sold his first company after scaling to 80,000+ users and raised over £2M in funding. He founded DealflowAgent to combine traditional M&A expertise with AI technology, creating aligned advisory solutions for SME business owners. Joe regularly speaks on exit planning and M&A trends, and has built a network of thousands of strategic acquirers across UK and US markets. [LinkedIn](https://www.linkedin.com/in/jp-lewin/) Valuation guides ## What is your business actually worth? Sector by sector benchmarks built from real completed transactions, with the valuation bands acquirers underwrite against. - [Fire Safety Business Valuation & EBITDA Multiples What fire alarm, extinguisher, sprinkler and passive fire protection businesses sell for, band by band. ](/valuation/fire-safety-multiples) - [Security Systems Business Valuation & EBITDA Multiples CCTV, access control, intruder alarms and monitoring: the multiples acquirers are paying in 2026. ](/valuation/security-systems-multiples) - [Compliance, Testing & Inspection Valuation Guide Why recurring statutory inspection revenue attracts the highest multiples in building services. ](/valuation/compliance-testing-inspection-multiples) - [Electrical Contracting Valuation & EBITDA Multiples NICEIC, EICR and EV infrastructure: how electrical contractors are valued and sold. ](/valuation/electrical-multiples) - [HVAC, Refrigeration & Cooling Valuation Guide Service contract density, engineer retention and the multiples HVAC consolidators pay. ](/valuation/hvac-multiples) [All valuation guides](/valuation/guides) [Free valuation tool](/valuation) [All articles](/blog) ## Keep reading [ ![Welcome Nick Barker as an Industry Partner: Valuation Gaps and Key-Person Dependency](/__l5e/assets-v1/65c42b7f-b12d-46f7-b4e0-63df6f3383e6/fm-talent-partners-dealflowagent-cover.png) M&A Strategy ### Welcome Nick Barker as an Industry Partner: Valuation Gaps and Key-Person Dependency We welcome Nick Barker of FM Talent Partners as an industry partner, supporting business owners and buyers with leadership hiring and two-way referrals. Aug 5, 2026 12 min read Read the full article ](/blog/valuation-gaps-key-person-dependency-fm-talent-partners) [ ![UK Electrical Contractor M&A 2026: EV and NICEIC](/covers/uk-electrical-contractor-ma-ev-niceic-2026.jpg) M&A Strategy ### UK Electrical Contractor M&A 2026: EV and NICEIC How UK electrical contractors are valued in 2026 - EAS October qualification deadline, EV grant uplift, EBITDA multiples 3x-11x, named UK buyers. May 26, 2026 11 min read Read the full article ](/blog/uk-electrical-contractor-ma-ev-niceic-2026) [ ![UK Heat Pump Installer M&A 2026: PE Roll-Up Map](/covers/uk-heat-pump-installer-ma-pe-roll-up-2026.jpg) M&A Strategy ### UK Heat Pump Installer M&A 2026: PE Roll-Up Map How UK heat pump installers are valued in 2026 - BUS extension to 2030, £9k oil/LPG grant, named PE buyers, EBITDA multiples 4x-12x and MCS premium. May 25, 2026 12 min read Read the full article ](/blog/uk-heat-pump-installer-ma-pe-roll-up-2026) [ ![How to Talk to Directors, Key Staff, and Employees Before a Possible Sale](/covers/pre-sale-communication-team-directors-employees.jpg) M&A Strategy ### How to Talk to Directors, Key Staff, and Employees Before a Possible Sale Preparing for a possible business sale creates sensitive communication problems with directors, equity holders, key employees, and the wider team. This practical founder guide explains how to protect morale, retain key people, manage earnout expectations, and use a diagnostic review before discussing a potential exit. May 18, 2026 22 min read Read the full article ](/blog/pre-sale-communication-team-directors-employees) [ ![Veterinary Practice Valuation UK 2026](/covers/veterinary-practice-valuation-uk-2026.jpg) M&A Strategy ### Veterinary Practice Valuation UK 2026 How UK veterinary practices are valued in 2026 - post-CMA outlook, EBITDA multiples 4x-12x, the named UK buyer landscape and 11 value drivers. May 18, 2026 12 min read Read the full article ](/blog/veterinary-practice-valuation-uk-2026) [ ![Fire Safety Acquisition Timeline UK 2026](/covers/fire-safety-acquisition-timeline-uk-2026.jpg) M&A Strategy ### Fire Safety Acquisition Timeline UK 2026 Realistic month-by-month UK fire safety business acquisition timeline for 2026, from advisor engagement to completion, with the sector-specific variables that compress or stretch each phase. May 7, 2026 14 min read Read the full article ](/blog/fire-safety-acquisition-timeline-uk-2026) ## Latest announcements [![Building & Facilities News names DealFlowAgent Company of the Month announcement cover](/assets/company-of-the-month-building-facilities-news-2026-Br7-aO4K.jpg)Company of the Month Building & Facilities News names DealFlowAgent Company of the Month The July 2026 feature on sector specialism, buyer relationships and what actually drives value for owners. ](/blog/company-of-the-month-building-facilities-news-2026)[![Martin Watson joins DealFlowAgent announcement cover](/__l5e/assets-v1/cb678acf-553d-43d7-85f3-82f6c174523b/martin-watson-joins-dealflowagent-cover.png)Senior Industry Advisor Martin Watson joins DealFlowAgent Chair of both the Fire Industry Association and the British Security Industry Association, after three decades in fire and security including Mitie. ](/blog/martin-watson-joins-dealflowagent-fire-security-advisory)[![Nick Barker joins as Industry Partner announcement cover](/__l5e/assets-v1/65c42b7f-b12d-46f7-b4e0-63df6f3383e6/fm-talent-partners-dealflowagent-cover.png)Industry Partner Nick Barker joins as Industry Partner Founder of FM Talent Partners, helping owners close key-person dependency gaps before a sale and connecting buyers with senior operators. ](/blog/valuation-gaps-key-person-dependency-fm-talent-partners) [![DealFlowAgent](/assets/dealflowagent-logo-white-BtiUZq_y.webp)](/) Specialist M&A advisory for Building Services, Facilities Management, and Healthcare business owners. Dedicated advisors, systematic buyer research, confidential process. London HQ · Battersea Power Station, SW11 8BZ New York · Manhattan, NY ### Building Services - [Fire Safety & Security](/fire-safety) - [HVAC & Heating](/hvac) - [Heat Pumps](/home-services/heat-pumps) - [Electricians](/home-services/electricians) - [CCTV](/home-services/cctv) - [Access Control](/home-services/access-control) - [Security Guarding](/home-services/security-guarding) - [Water Hygiene](/home-services/water-hygiene) - [Browse all 30+ sectors →](/home-services) ### Healthcare - [Dental Practices](/healthcare/dental) - [Care Homes](/healthcare/care-home) - [Veterinary](/healthcare/veterinary) - [Personal Care](/healthcare/personal-care) - [Podiatry](/healthcare/podiatry) - [Urgent Care](/healthcare/urgent-care) - [Dermatology](/healthcare/dermatology) - [Browse all healthcare →](/healthcare) ### Technology & Professional Services - [B2B SaaS & Technology](/technology) - [IT Managed Services](/technology/it-managed-services) - [Accounting Firms](/technology/accounting-firms) - [Law Firms](/technology/law-firms) - [Insurance Brokerage](/technology/insurance-brokerage) - [Digital Marketing Agencies](/technology/digital-marketing-agency) - [E-Commerce](/ecommerce) ### Sell Your Business - [AI M&A Marketplace](/marketplace) - [Buyer Intelligence](/buyer-match) - [Valuation Guides](/valuation/guides) - [Already Approached?](/already-approached) - [Live Mandates](/mandates) ### For Buyers - [Sterling: AI Deal Sourcing](/sterling) - [Buyer Match](/buyer-match) - [Buyer Registration](/buyside) - [Live Mandates](/mandates) - [All Listings](/for-sale) - [Featured Opportunities](/opportunities) ### Resources - [Blog & Insights](/blog) - [Valuation Guides](/valuation/guides) - [Exit Planning](/exit-planning) - [Exit Readiness](/exit-readiness) - [AI Automation Guide](/ai-automation-for-service-businesses) - [Comparisons](/comparisons) - [Case Studies](/case-studies) - [Media / Press](/media) - [FAQ](/faq) - [Sitemap](/sitemap) ### Company - [About Us](/about) - [Contact](/contact) - [Careers](/careers) - [Pricing](/pricing) Building Services Healthcare Technology & Professional Services Sell Your Business For Buyers Resources Company Referral Programme ### Earn introducer fees on every successful deal Tailored programmes for sellers, buyers, advisors, and niche operators across building services, facilities management, and healthcare. [Programme overview](/referral) [→ Refer a Seller (Operators)](/referral/operators)[→ Refer a Buyer](/referral/buyers)[→ Advisor Referrals](/referral/advisors)[→ Embed the Valuation Widget](/partners/valuation-widget)[→ Building Services Referrals](/referral/operators)[→ Healthcare Referrals](/referral/operators)[→ Programme Overview](/referral) ### Locations [London](/locations/london)· [Manchester](/locations/manchester)· [Birmingham](/locations/birmingham)· [South East](/locations/south-east)· [Florida](/locations/florida)· [Miami](/locations/miami) ### Partnerships [Advisor Partnership](/advisorpartner)· [Strategic Partnerships](/partnerships)· [Buyers (Building Services)](/buyers-home-building-services)· [Radio Partner](/radio) © 2026 DealFlowAgent. All rights reserved. [Privacy Policy](/privacy)· [Terms of Service](/terms)· [Comparisons](/comparisons)· [Sitemap](/sitemap) [](https://www.linkedin.com/company/dealflowagent)[](https://twitter.com/dealflowagent)[](mailto:joe@dealflowagent.com) DealFlowAgent provides M&A advisory services. Investment outcomes are not guaranteed. Past performance is not indicative of future results. All transactions are subject to due diligence and regulatory approval where applicable. Menu Sectors Refer an Owner [Valuation Guides](/valuation/guides)[Exit Planning](/exit-planning)[Blog](/blog) Book a Confidential Call [Careers](/careers)[Message us on WhatsApp](https://wa.me/442072930327) [UK +44 20 7293 0327](tel:+442072930327)[US +1 (447) 837-9720](tel:+14478379720) [I'm an Owner](/valuation)[I'm a Buyer](/buyside)